TRADEAI NEWS
PlatformStocksGet started
Home›Stocks›ABCL

ABCL — structural market context

AbCellera Biologics Inc. Commo

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

ABCL short interest & days to cover

SHARES SHORT
48.3M
% OF FLOAT
23.6%
DAYS TO COVER
9.7
CHANGE VS PRIOR
+7.1%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (15d ago)

ABCL fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-07-14 · 32d47K$6.52
2026-07-13 · 33d3K$6.8
2026-07-10 · 36d2K$7.29

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

ABCL insider buying and selling (Form 4)

Last 12 months, open-market only: 2 purchases · 0 sales · 2 distinct buyers in 30 days

InsiderTypeSharesValueFiled
Booth Andrew · officer: Chief Financial OfficerBuy (P)37K$384K2026-08-14
Hayden Michael R · directorBuy (P)46K$481K2026-08-14

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is ABCL's short interest?
As of the FINRA settlement date 2026-07-31, ABCL had 48.3M shares sold short — 23.6% of its float, with 9.7 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying ABCL?
In the last 12 months of SEC Form 4 filings, ABCL recorded 2 open-market insider purchases and 0 open-market sales (codes P and S; grants and option exercises excluded). 2 distinct insiders bought within the last 30 days. These are attributed public records — information, not instruction.
Is this page telling me to buy or sell ABCL?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerAnalyst Accuracy trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.